© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 4, 300A-301,
February 16, 2000
© 2000 Oxford University Press
NEWS |
Awards, Appointments, Announcements
Patricia Ganz, M.D., has been named the first Professor of Survivorship by the Susan G. Komen Breast Cancer Foundation, and will receive a $20,000 honorarium for 1 year to support her research on quality of life in breast cancer survivors.
|
Ganz is the director of the Division of Cancer Prevention and Control Research at the University of California, Los Angeles, Jonsson Comprehensive Cancer Center. She is also a professor in UCLA’s Schools of Medicine and Public Health.
Her research will focus on how chemotherapy may negatively affect breast cancer patients’ abilities to concentrate and think clearly, influencing their long-term quality of life. Her past research focused on how breast cancer survivors fare in the months and years after treatment. She found that breast cancer survivors frequently enjoy better quality of life than women who do not have cancer because the experience with the disease often compels women to redefine the priorities in their lives.
Formenti Appointed
New York University School of Medicine, New York, has appointed Silvia Formenti, M.D., as the first Sandra and Edward H. Meyer Chairman of the Department of Radiation Oncology.
Formenti was an associate professor of radiation oncology and medicine at the University of California at Los Angeles School of Medicine prior to her move to New York. She is investigating the effects of combination therapy on the primary treatment of breast, prostate, and cervical cancer, and whether the response to treatment is associated with biological markers present in the original tumors.
Mortara Named
Isabel Mortara has been named the new executive director of the International Union Against Cancer, Geneva, Switzerland.
Mortara has been UICC’s deputy director since 1990 and head of the Education Department since 1985. "The UICC is a truly unique organization, the only one with a global mandate in all aspects of cancer control and one that has an impressive grass roots capacity through its prestigious international membership," Mortara said.
She replaced Archie J. Turnbull, who served as executive director for 10 years.
Grossman to Head Society
Stuart A. Grossman, M.D., has been named the president of the Society for Neuro-Oncology for a 2-year term. Grossman is a professor of oncology, medicine, and neurosurgery at the Johns Hopkins Oncology Center, Baltimore.
Since 1994, Grossman has directed the New Approaches to Brain Tumor Therapy brain tumor consortium. He is the director of the Clinical and Laboratory Neuro-Oncology Programs at the Oncology Center, and co-directs the Pain Team.
Gill Appointed
George M. Gill, M.D., has been named vice president for clinical research and regulatory affairs at Genetronics Inc., a San Diego-based drug and DNA delivery company.
Prior to his appointment, Gill was vice president of medical affairs at Ligand Pharmaceuticals, San Diego. He has also served as senior director of clinical and medical affairs of ICI Pharmaceuticals (now Zeneca), vice president of worldwide regulatory affairs of Bristol-Myers Squibb, and director of the Oncology Clinical Research Group at Hoffmann-LaRoche.
"[Gill] has the background, knowledge, and extensive managerial talent that Gentronics needs now and in the future," said Martin Nash, chief executive officer of Genetronics.
Gershenson Named
The University of Texas M. D. Anderson Cancer Center has appointed David Gershenson, M.D., as the chairman of the Department of Gynecologic Oncology.
Gershenson has been on the faculty at M. D. Anderson for 20 years, and will continue to direct the Blanton-Davis Ovarian Cancer Research Program, which he helped establish in 1996.
He is the principal investigator of M. D. Anderson’s Gynecologic Oncology Group, and is the co-principal investigator of the Specialized Program of Research Excellence grant in ovarian cancer.
"[Gershenson] has contributed in many ways to the outstanding international reputation that the Gynecologic Oncology faculty and staff have earned," said John Mendelsohn, M.D., president of M. D. Anderson.
Book for Teens Published
Teenage Cancer Journey, a book written from a teen’s perspective on what it’s like to be confronted with cancer, is now available from Oncology Nursing Press Inc., Pittsburgh.
The book was written by Kathleen Gill, a cancer survivor. She addresses the unique issues that face young people who have been diagnosed with cancer, such as losing their hair, relating to friends and family who are not sick, and balancing school responsibilities while undergoing treatment.
The book may be ordered by calling 412-921-7373, or by sending $18 to Oncology Nursing Press Inc., P.O. Box 400295, Pittsburgh, PA 15268-0295.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||